[go: up one dir, main page]

NO20005128L - Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH - Google Patents

Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH

Info

Publication number
NO20005128L
NO20005128L NO20005128A NO20005128A NO20005128L NO 20005128 L NO20005128 L NO 20005128L NO 20005128 A NO20005128 A NO 20005128A NO 20005128 A NO20005128 A NO 20005128A NO 20005128 L NO20005128 L NO 20005128L
Authority
NO
Norway
Prior art keywords
carnitine
nadh
nadph
alkanoyl
composition
Prior art date
Application number
NO20005128A
Other languages
Norwegian (no)
Other versions
NO20005128D0 (en
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20005128D0 publication Critical patent/NO20005128D0/en
Publication of NO20005128L publication Critical patent/NO20005128L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20005128A 1998-04-17 2000-10-12 Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH NO20005128L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (2)

Publication Number Publication Date
NO20005128D0 NO20005128D0 (en) 2000-10-12
NO20005128L true NO20005128L (en) 2000-12-18

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005128A NO20005128L (en) 1998-04-17 2000-10-12 Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH

Country Status (17)

Country Link
EP (1) EP1071424A1 (en)
JP (1) JP2002512191A (en)
KR (1) KR20010042765A (en)
CN (1) CN1299283A (en)
AU (1) AU750645B2 (en)
BR (1) BR9909712A (en)
CA (1) CA2328331A1 (en)
EE (1) EE200000601A (en)
HU (1) HUP0101914A3 (en)
IL (1) IL139014A0 (en)
IS (1) IS5663A (en)
IT (1) IT1299161B1 (en)
NO (1) NO20005128L (en)
PL (1) PL343482A1 (en)
SK (1) SK15442000A3 (en)
TR (1) TR200002894T2 (en)
WO (1) WO1999053921A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (en) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Dietary supplement, e.g. for increasing general performance, concentration and endurance, comprises NADH, L-carnitine, coenzyme Q10, L-carnosine, succinic acid, ascorbic acid and bioflavonoids
JP2009532509A (en) * 2007-05-11 2009-09-10 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Gels useful for the delivery of cosmetic active ingredients
US20120214870A1 (en) * 2009-08-31 2012-08-23 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (en) * 2014-10-23 2015-01-28 苏州人本药业有限公司 Application of reduced coenzyme II
CN104840479A (en) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Application of NADPH in preparation of drugs used for treating heart diseases
US10894059B2 (en) * 2017-12-22 2021-01-19 Bontac Bio-Engineering (Shenzhen) Co., Ltd NADH compound composition, and preparation and use thereof
WO2019200491A1 (en) 2018-04-20 2019-10-24 Pacotrade Ag Device for crushing deep-frozen foodstuffs provided in block form
CN109170907A (en) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 A kind of preparation method of composition containing NMN, application and sports drink
CN109105702A (en) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 A kind of preparation method of composition containing NADH, application and energy extender
EP3864969A4 (en) * 2018-10-10 2022-06-15 Leung, So Ngor Sally COMPOSITION OF A HEALTH PRODUCT FOR COMPENSATING A DEFICIT, METHOD FOR PREPARING IT AND ITS APPLICATION
CN117958433A (en) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 Caffeine-free anti-fatigue functional composition and beverage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (en) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
JPH09110708A (en) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd Nutritional tonic crude drug combination preparation
JPH0959161A (en) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd Fatigue improving composition
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283951B1 (en) * 1996-03-15 1998-05-07 Mendes Srl USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (en) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd Fatigue improver

Also Published As

Publication number Publication date
KR20010042765A (en) 2001-05-25
PL343482A1 (en) 2001-08-27
IT1299161B1 (en) 2000-02-29
CA2328331A1 (en) 1999-10-28
JP2002512191A (en) 2002-04-23
SK15442000A3 (en) 2001-06-11
EP1071424A1 (en) 2001-01-31
AU750645B2 (en) 2002-07-25
IL139014A0 (en) 2001-11-25
TR200002894T2 (en) 2001-01-22
BR9909712A (en) 2000-12-26
IS5663A (en) 2000-10-13
NO20005128D0 (en) 2000-10-12
ITRM980238A1 (en) 1999-10-17
HUP0101914A3 (en) 2002-12-28
EE200000601A (en) 2002-04-15
WO1999053921A1 (en) 1999-10-28
AU3442899A (en) 1999-11-08
ITRM980238A0 (en) 1998-04-17
CN1299283A (en) 2001-06-13
HUP0101914A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
NO995784D0 (en) Phytosterol and / or phytosterol derivatives
NO996491L (en) 4-bromo or 4-iodo-phenylaminobenzhydroxamic acid derivatives and their use as MEK inhibitors
NO985039D0 (en) Alkyl-4-silyl phenols and esters thereof as antiatherosclerotic agents
DK1032575T3 (en) 2,3-diaryl-pyrazole (1,5-b) pyridazine derivatives, their preparation and use as cyclooxygenase 2 (COX-2) inhibitor
DK1112005T4 (en) Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid
DK1112003T3 (en) New composition and application
DK0857087T3 (en) Coating composition with antimicrobial action in can and dry film
NO20006488D0 (en) Composition and application
NO20005191D0 (en) Glass-ceramic coatings and sealing arrangements, and their use in brake cells
DK1375503T3 (en) Dioxin derivatives and their use as dopamine agonists
NO20005128L (en) Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH
DE69926046D1 (en) thrust bearing
DK1012137T3 (en) Aromatic C-16-C-20-substituted tetrahydro-prostaglandins and their use as prostaglandin FP agonists
NO993467D0 (en) Granules comprising clavulanate and one or more excipients
DK0989121T3 (en) Substituted benzamides and their use as immunomodulators
NO994510L (en) Substituted isoquinoline derivatives and their use as anticonvulsants
NO995513D0 (en) N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
NO985891D0 (en) Substituted benzamide derivatives and their use as anticonvulsants
DE69937060D1 (en) IMMUNOGENIC COMPOSITIONS AND ITS USES
NO986034D0 (en) Combinations comprising VX 478, ZidovudÞn, FTC and / or 3TC for use
NO990440D0 (en) Preparation that includes mupirocin and chlorhexidine
NO20012973D0 (en) Polyester-polyurethane glue and its use
DK1214302T3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones and their use as lipase inhibitors
NO20004904L (en) C11 oxymyl and hydroxylaminoprostaglandins useful as medicaments
NO20006626D0 (en) Coating agent and its use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application